Prognostic indicators of improvement with therapeutic plasma exchange in pediatric demyelination
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received March 11, 2019
- Accepted in final form July 19, 2019
- First Published October 23, 2019.
Article Versions
- Previous version (October 23, 2019 - 12:45).
- You are viewing the most recent version of this article.
Author Disclosures
- Andrea Savransky, MD,
- Adrian Rubstein, MD,
- Marina Huaman Rios, MD,
- Silvana L. Vergel, MD,
- Mabel Castro Velasquez, MD,
- Sara Perez Sierra, MD,
- Gabriela Marcarian, MD,
- Romina Alba, MD,
- Ana M. Pugliese, MD and
- Silvia Tenembaum, MD
- Andrea Savransky, MD,
NONE
NONE
Dr. Savransky received honoraria from Genzyme de Argentina SA to present a lecture on "Argentinian school of neuroinmunology" on 9/22/2017
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Adrian Rubstein, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Marina Huaman Rios, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Silvana L. Vergel, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Mabel Castro Velasquez, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Sara Perez Sierra, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Gabriela Marcarian, MD,
NONE
NONE
Terumo BCT, funding for scientific travel grants
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Romina Alba, MD,
NONE
NONE
Terumo BCT, grants for scientific travel
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ana M. Pugliese, MD and
NONE
NONE
(1) Terumo BCT. Cash. By donation to the Garrahan Foundation for medical education.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Silvia Tenembaum, MD
Commercial entity: (1) Scientific advisory board: Novartis Argentina 2018.
NONE
(1) Merck LATAM: funding for travel to ECTRIMS 2017; ECTRIMS 2018; AAN 2019. (2) Biogen Argentina: funding for travel to AAN 2018. (3) Speaker honoraria from: Genzyme Argentina SA (2017, 2018); Biogen Argentina (2018); Merck S.A. LATAM (2018;2019); Novartis Argentina S.A. 2018.
(1) Neurology: Neuroimmunology & Neuroinflammation: non- remunerated Editorial board member (2016-2019) (2) Frontiers in Neurology: non-remunerated Editorial board member (2018-2019) 3) Neurology and Therapy: non-remunerated Editorial board member (April 2019)
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Neurology (A.S., M.H.R., S.L.V., M.C.V., S.P.S., S.T.) and Transfusion Medicine (G.M., R.A., A.M.P.), National Pediatric Hospital Dr. J.P. Garrahan; and Private Institute of Statistics (A.R.), Buenos Aires, Argentina.
- Correspondence
Dr. Tenembaum silviatenembaum{at}gmail.com
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
More Online
Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study
Dr. Robert Shapiro and Dr. Amynah Pradhan